insights_auto
Why is NTRA down 5.70%?
Dive Deeperchevron_right
NTRA:NASDAQ
Natera Inc
$273.40
arrow_downward
-5.70%(-16.52) 1D
$274.16
arrow_upward
+0.28% (+0.76)bedtimeAfter hours
Closed: Nov 20, 4:00:03 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NTRA...
Open
$286.68
High
$288.40
Low
$271.85
Mkt. cap
39.64B
Avg. vol.
1.96M
Volume
1.39M
52-wk high
$437.41
52-wk low
$181.00
EPS
-$1.14
Beta
1.55
Shares outstanding
145.00M
No. of employees
6K
Open
$286.68
High
$288.40
Low
$271.85
Mkt. cap
39.64B
Avg. vol.
1.96M
Volume
1.39M
52-wk high
$437.41
52-wk low
$181.00
EPS
-$1.14
Beta
1.55
Shares outstanding
145.00M
No. of employees
6K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 day ago
Natera stock targets more than $6 billion revenue by 2029
Investing.com
·
2 days ago
UBS reiterates Natera stock rating on CEO transition confidence
The Motley Fool
·
2 days ago
Natera vs. Tempus AI: Which Blood Test Pioneer Has the Better Stock Buy for 2027?
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6.14K
FoundedJan 1, 2004
HeadquartersAustin, Texas, United States
SectorHealth Care
IndustryBiotechnology
Websitenatera.com